Detalles de la búsqueda
1.
Experiences of male partners of women with endometriosis-associated pelvic pain: a qualitative study.
Eur J Contracept Reprod Health Care
; 27(6): 454-460, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35867527
2.
Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months.
Eur J Contracept Reprod Health Care
; 25(2): 133-140, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32069126
3.
Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial.
Eur J Contracept Reprod Health Care
; 23(5): 344-350, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30372645
4.
Relationship between user satisfaction with the levonorgestrel-releasing intrauterine system and bleeding patterns.
J Obstet Gynaecol Res
; 43(11): 1732-1737, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28833891
5.
Assessment of the availability of sexual and reproductive healthcare for Venezuelan migrant women during the SARS-CoV-2 pandemic at the north-western border of Brazil-Venezuela.
J Migr Health
; 5: 100092, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35313677
6.
Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
Fertil Steril
; 110(6): 1129-1136, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30396557
Resultados
1 -
6
de 6
1
Próxima >
>>